Extended-Spectrum β-Lactamases: Frequency, Risk Factors, and Outcomes
- 1 January 2002
- journal article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 22 (1) , 14-20
- https://doi.org/10.1592/phco.22.1.14.33497
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Infection and Impact of Resistance on OutcomesClinical Infectious Diseases, 2001
- Control of a Prolonged Outbreak of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in a University HospitalClinical Infectious Diseases, 1999
- Successful Interventions for Gram-Negative Resistance to Extended-Spectrum β-Lactam AntibioticsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Colonization with broad-spectrum cephalosporin-resistant Gram-negative bacilli in intensive care units during a nonoutbreak periodCritical Care Medicine, 1999
- Extended-spectrum plasmid-mediated -lactamasesJournal of Antimicrobial Chemotherapy, 1995
- Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation CephalosporinsAnnals of Internal Medicine, 1993
- Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patientsAntimicrobial Agents and Chemotherapy, 1992
- A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamaseJournal of Hospital Infection, 1991
- Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facilityAntimicrobial Agents and Chemotherapy, 1990
- TRANSFERABLE ENZYMATIC RESISTANCE TO THIRD-GENERATION CEPHALOSPORINS DURING NOSOCOMIAL OUTBREAK OF MULTIRESISTANT KLEBSIELLA PNEUMONIAEThe Lancet, 1987